Technologies

Technologies

Philogen´s research and development activities for the identification of novel targeting agents rely on proprietary technology platforms such as  antibody libraries and DNA-encoded chemical libraries. Both platforms have proven to deliver best-in-class ligands with high affinity and specificity and with powerful in vivo targeting properties.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.

I Accept Cookie Policy
X